NIH Study Finds Testosterone May Slow Male Brain Tumor Growth
Research funded by NIH suggests testosterone reduces glioblastoma progression in males and is linked to improved survival in patients
Archive 
UnitedHealthcare to Eliminate Prior Authorization for 30% of Treatments
UnitedHealthcare will remove prior authorization requirements for nearly a third of medical services to streamline patient access and reduce administrative delays by the end…
Oral GLP-1 Weight-Loss Drugs Target Brain’s Reward Circuit to Curb Cravings
NIH-funded study finds that small-molecule GLP-1 drugs reach deep brain reward centers to reduce pleasure-driven eating in mice
FDA Authorizes Fruit-Flavored E-Cigarettes for Adult Smokers
The FDA approved fruit-flavored vaping products for adults, marking a significant policy shift amid declining teen vaping rates and ongoing scrutiny
FDA Authorizes Four New ENDS Pods with Age-Restriction Technology
The FDA has approved marketing of four Glas e-cigarette pods featuring advanced age verification to prevent youth use while expanding adult access to non-tobacco…
Elisabeth Armstrong Named NIH Chief of Staff
Elisabeth Armstrong joins the NIH Office of the Director to oversee operations and advise leadership with broad public and private sector experience
Suspected Hantavirus Outbreak Strands Passengers on Cruise Ship
A suspected hantavirus outbreak aboard the MV Hondius has infected about 150 people and caused at least three deaths, prompting ongoing investigations and quarantine…
WHO Reports Possible Human-to-Human Hantavirus Transmission on Cruise Ship
The World Health Organization says hantavirus may have spread between people aboard a cruise ship off Cape Verde, with three deaths and multiple infections…
FDA Reports Low Contaminant Levels in Largest U.S. Infant Formula Study
The FDA’s comprehensive testing of over 300 infant formula samples found low contaminant levels, affirming the safety of the U.S. formula supply while promising…
FDA Proposes Excluding Semaglutide, Tirzepatide, Liraglutide from 503B Bulks List
The FDA proposes to exclude three diabetes-related drugs from the list of bulk substances allowed for compounding by outsourcing facilities due to lack of…